53 related articles for article (PubMed ID: 8171622)
1. Rejection of human islet allografts in human lymphocyte-reconstituted severe combined immunodeficient mice.
Shiroki R; Poindexter NJ; Mohanakumar T; Scharp DW
Transplant Proc; 1994 Apr; 26(2):716-7. PubMed ID: 8171622
[No Abstract] [Full Text] [Related]
2. Human peripheral blood lymphocyte reconstituted severe combined immunodeficient (hu-PBL-SCID) mice. A model for human islet allograft rejection.
Shiroki R; Poindexter NJ; Woodle ES; Hussain MS; Mohanakumar T; Scharp DW
Transplantation; 1994 Jun; 57(11):1555-62. PubMed ID: 8009588
[TBL] [Abstract][Full Text] [Related]
3. Rejection of human islets and human HLA-A2.1 transgenic mouse islets by alloreactive human lymphocytes in immunodeficient NOD-scid and NOD-Rag1(null)Prf1(null) mice.
Banuelos SJ; Shultz LD; Greiner DL; Burzenski LM; Gott B; Lyons BL; Rossini AA; Appel MC
Clin Immunol; 2004 Sep; 112(3):273-83. PubMed ID: 15308121
[TBL] [Abstract][Full Text] [Related]
4. Severe combined immunodeficient mice engrafted with human splenocytes have functional human T cells and reject human allografts.
Alegre ML; Peterson LJ; Jeyarajah DR; Weiser M; Bluestone JA; Thistlethwaite JR
J Immunol; 1994 Sep; 153(6):2738-49. PubMed ID: 8077678
[TBL] [Abstract][Full Text] [Related]
5. Nature of tolerance induction to peripheral (extrathymic) islet allografts.
Coulombe M; Lafferty KJ; Gill RG
Transplant Proc; 1994 Apr; 26(2):720-1. PubMed ID: 8171624
[No Abstract] [Full Text] [Related]
6. Long-term chimera produced by transplantation of human fetal liver cells into severe combined immunodeficiency mice.
Sanhadji K; Chargui J; Touraine JL
Transplant Proc; 1993 Feb; 25(1 Pt 1):452. PubMed ID: 8438375
[No Abstract] [Full Text] [Related]
7. Stimulating PD-1-negative signals concurrent with blocking CD154 co-stimulation induces long-term islet allograft survival.
Gao W; Demirci G; Strom TB; Li XC
Transplantation; 2003 Sep; 76(6):994-9. PubMed ID: 14508368
[TBL] [Abstract][Full Text] [Related]
8. Acceptance of islet allografts in the liver of mice by blockade of an inducible costimulator.
Nakamura Y; Yasunami Y; Satoh M; Hirakawa E; Katsuta H; Ono J; Kamada M; Todo S; Nakayama T; Taniguchi M; Ikeda S
Transplantation; 2003 Apr; 75(8):1115-8. PubMed ID: 12717187
[TBL] [Abstract][Full Text] [Related]
9. Anergic cells generated in vitro suppress rejection response to islet allografts.
Luo Z; Gotoh M; Grochowiecki T; Tanaka T; Kimura F; Kawashima H; Yagita H; Okumura K; Miyasaka M
Transplant Proc; 1999; 31(1-2):623. PubMed ID: 10083265
[No Abstract] [Full Text] [Related]
10. Fine specificity of class I MHC recognition in islet allografts.
Ferguson D; Kohli N; Munn SR
Transplant Proc; 1995 Dec; 27(6):3222. PubMed ID: 8539924
[No Abstract] [Full Text] [Related]
11. Cellular requirements for pancreatic islet xenograft rejection.
Ahn M; Chang E; Chu G; Barker CF; Markmann JF
Transplant Proc; 1995 Dec; 27(6):3302-3. PubMed ID: 8539963
[No Abstract] [Full Text] [Related]
12. IL-2 and IL-4 double knockout mice reject islet allografts: a role for novel T cell growth factors in allograft rejection.
Li XC; Roy-Chaudhury P; Hancock WW; Manfro R; Zand MS; Li Y; Zheng XX; Nickerson PW; Steiger J; Malek TR; Strom TB
J Immunol; 1998 Jul; 161(2):890-6. PubMed ID: 9670967
[TBL] [Abstract][Full Text] [Related]
13. The diabetic "human reconstituted" severe combined immunodeficient (SCID-hu) mouse: a model for isogeneic, allogeneic, and xenogeneic human islet transplantation.
London NJ; Thirdborough SM; Swift SM; Bell PR; James RF
Transplant Proc; 1991 Feb; 23(1 Pt 1):749. PubMed ID: 1990677
[No Abstract] [Full Text] [Related]
14. Analysis of cytokine transcripts in pancreatic islet cell allografts during rejection and tolerance induction.
Nickerson P; Pacheco-Silva A; O'Connell PJ; Steurer W; Kelley VR; Strom TB
Transplant Proc; 1993 Feb; 25(1 Pt 2):984-5. PubMed ID: 8442291
[No Abstract] [Full Text] [Related]
15. Role of intra-islet endothelial cells in islet allo-immunity.
Bharat A; Saini D; Benshoff N; Goodman J; Desai NM; Chapman WC; Mohanakumar T
Transplantation; 2007 Nov; 84(10):1316-23. PubMed ID: 18049117
[TBL] [Abstract][Full Text] [Related]
16. T lymphocyte indifference to extrathymic islet allografts.
Coulombe M; Gill RG
J Immunol; 1996 Mar; 156(5):1998-2003. PubMed ID: 8596055
[TBL] [Abstract][Full Text] [Related]
17. Engraftment and activity of anti-CD3-activated human peripheral blood lymphocytes transferred into mice with severe combined immune deficiency.
Murphy WJ; Conlon KC; Sayers TJ; Wiltrout RH; Back TC; Ortaldo JR; Longo DL
J Immunol; 1993 Apr; 150(8 Pt 1):3634-42. PubMed ID: 8468492
[TBL] [Abstract][Full Text] [Related]
18. Islets of Langerhans rejection: allo vs xenotransplantation in animals.
Bühler L; Deng S; Mage SR; Bubloz C; Rohner A; Morel P
Transplant Proc; 1994 Apr; 26(2):764-5. PubMed ID: 8171653
[No Abstract] [Full Text] [Related]
19. Tissue immunogenicity: the role of MHC antigen and the lymphocyte costimulator B7-1.
Coulombe M; Yang H; Guerder S; Flavell RA; Lafferty KJ; Gill RG
J Immunol; 1996 Dec; 157(11):4790-5. PubMed ID: 8943380
[TBL] [Abstract][Full Text] [Related]
20. Human peripheral blood lymphocyte-reconstituted, severe combined immunodeficient mice as a model for porcine islet xenograft rejection in humans.
Shiroki R; Nazirrudin B; Hoshinaga K; Naide Y; Scharp DW; Mohanakumar T
Artif Organs; 1996 Aug; 20(8):878-82. PubMed ID: 8853799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
